Generic PPIs Look For Long-Term Formulary Benefit From Prilosec OTC
This article was originally published in The Tan Sheet
Executive Summary
Price pressures caused by the availability of Procter & Gamble's Prilosec OTC may offer potential upsides for generic omeprazole offerings regarding favorable formulary status, according to insurers
You may also be interested in...
Mylan Says PPI Formulary Impact Unclear As Omeprazole Options Increase
Prescription proton pump inhibitor manufacturers are becoming increasingly wary of the effect Prilosec OTC will have on the formulary status of generic offerings
AstraZeneca Sees Prilosec OTC As “Neutral To Beneficial” For Nexium Sales
The effect Prilosec OTC has on health plan formularies may provide an upshot for sales of AstraZeneca's follow-on Nexium (esomeprazole), CFO Jonathan Symonds said during an Oct. 23 earnings call
Prilosec OTC Has Retailers Staying Up Late; “BurnTown” Preview Underway
Wal-Mart is shipping "pre-awareness" promotional kits for Procter & Gamble's Prilosec OTC (omeprazole) to its stores in anticipation of the heartburn prevention drug's Sept. 15 launch